Clinical Trial Update: Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating allogeneic bone marrow-derived mesenchymal stem cells for lumbar facet arthropathy presenting as facet-mediated low back pain; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facet-mediated Low Back Pain
• Lumbar Facet Arthropathy

Drugs mentioned

• Allogeneic bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: Facet-Mediated Low Back Pain | Phase 1 | Status: COMPLETED